Brazil private clinics seek deal with Bharat Biotech for vaccine
The Brazilian Association of Vaccine Clinics (ABCVAC) has said that it is negotiating with Indian firm Bharat Biotech to buy 50 lakh doses of its COVID-19 vaccine, Covaxin. Any final deal would be subject to approval by Brazil's health regulator, ANVISA. On Sunday, India granted emergency use approval for Covaxin, which is currently under Phase 3 clinical trials.